CME Group (CME) Expected to Release Quarterly Earnings on Wednesday

CME Group (NASDAQ:CME) is projected to release its Q2 2026 results before the market opens on Wednesday, July 22nd. Analysts expect CME Group to post earnings of $2.98 per share and revenue of $1.7102 billion for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, July 22, 2026 at 8:30 AM ET.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating the consensus estimate of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter last year, the business earned $2.80 earnings per share. On average, analysts expect CME Group to post $12 EPS for the current fiscal year and $13 EPS for the next fiscal year.

CME Group Price Performance

Shares of NASDAQ:CME opened at $243.61 on Wednesday. The firm has a market capitalization of $88.27 billion, a price-to-earnings ratio of 20.79, a price-to-earnings-growth ratio of 2.89 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50 day simple moving average is $260.94 and its 200-day simple moving average is $282.82. CME Group has a 12 month low of $218.31 and a 12 month high of $329.16.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Insider Buying and Selling at CME Group

In other news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This represents a 38.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director William R. Shepard bought 325 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On CME Group

A number of institutional investors have recently added to or reduced their stakes in the company. Empowered Funds LLC lifted its stake in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after purchasing an additional 1,037 shares in the last quarter. Marshall Wace LLP raised its holdings in CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after buying an additional 121,707 shares during the period. Federated Hermes Inc. raised its holdings in CME Group by 1,325.2% in the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after buying an additional 21,918 shares during the period. Nebula Research & Development LLC purchased a new position in CME Group in the second quarter valued at approximately $992,000. Finally, The Manufacturers Life Insurance Company lifted its position in CME Group by 2.6% during the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after buying an additional 7,397 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on CME. Weiss Ratings lowered CME Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research report on Thursday, April 16th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and raised their price target for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. Finally, Morgan Stanley cut their price target on CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a report on Friday, July 10th. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $293.59.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.